The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
The Measurement of Dyspnea
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148
A Coefficient of Agreement for Nominal Scales
Cohen, J. (1960) · Educational and Psychological Measurement · doi:10.1177/001316446002000104 · Cited by 42,398
Huskisson, E. C. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90884-8 · Cited by 4,522
Clinical biostatistics: LIV. The biostatistics of concordance
Kramer, M. S., & Feinstein, A. R. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.18 · Cited by 1,087
Self-citationSignificance of Respiratory Symptoms and the Diagnosis of Chronic Bronchitis in a Working Population
Fletcher, C. M., Elmes, P. C., Fairbairn, A. S., & Wood, C. H. (1959) · BMJ · doi:10.1136/bmj.2.5147.257 · Cited by 971
A Means of Assessing Maximal Oxygen Intake: Correlation Between Field and Treadmill Testing
Cooper, K. H. (1968) · JAMA · doi:10.1001/jama.1968.03140030033008 · Cited by 769
Durnin, J. V. G. A., & PASSMORE, R. (1967) · Heinemann Educational Books · Cited by 597
Comparison of fixed interval and visual analogue scales for rating chronic pain
Joyce, C. R. B., Zutshi, D. W., Hrubes, V., & Mason, R. M. (1975) · European Journal of Clinical Pharmacology · doi:10.1007/bf00562315 · Cited by 539
Statistics: A Biomedical Introduction
Krótki, K. J., Brown, B. W., Hollander, M., & Krotki, K. J. (1980) · International Statistical Review / Revue Internationale de Statistique · doi:10.2307/1402416 · Cited by 445
McGavin, C. R., Artvinli, M., Naoe, H., & McHardy, G. J. (1978) · BMJ · doi:10.1136/bmj.2.6132.241 · Cited by 434
Cited by
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
Spruit, M. A., Singh, S. J., Garvey, C., ZuWallack, R., Nici, L., Rochester, C., Hill, K., Holland, A. E., Lareau, S. C., Man, W. D.-C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1634st · Cited by 3,938
The St George's Respiratory Questionnaire
Jones, P. W., Quirk, F. H., & Baveystock, C. M. (1991) · Respiratory Medicine · doi:10.1016/s0954-6111(06)80166-6 · Cited by 2,683
Pulmonary rehabilitation for chronic obstructive pulmonary disease
McCarthy, B., Casey, D., Devane, D., Murphy, K., Murphy, E., & Lacasse, Y. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003793.pub3 · Cited by 2,643
Evaluation of Clinical Methods for Rating Dyspnea
Mahler, D. A., & Wells, C. K. (1988) · Chest · doi:10.1378/chest.93.3.580 · Cited by 1,822
Self-citationGeneric and Disease-Specific Measures in Assessing Health Status and Quality of Life
Patrick, D. L., & Deyo, R. A. (1989) · Medical Care · doi:10.1097/00005650-198903001-00018 · Cited by 1,790
Inhaled Iloprost for Severe Pulmonary Hypertension
Olschewski, H., Simonneau, G., Galiè, N., Higenbottam, T., Naeije, R., Rubin, L. J., Nikkho, S., Speich, R., Hoeper, M. M., Behr, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020204 · Cited by 1,783
A measure of quality of life for clinical trials in chronic lung disease
Guyatt, G. H., Berman, L. B., Townsend, M., Pugsley, S. O., & Chambers, L. W. (1987) · Thorax · doi:10.1136/thx.42.10.773 · Cited by 1,721
“Questionnaires that have been developed for this purpose include the oxygen cost diagram7 and the baseline and transition dyspnoea indexes.8 These tools address patients' dyspnoea but do not focus on the many other aspects of their lives that are affected by the illness.”
BackgroundCyclophosphamide versus placebo in scleroderma lung disease
Tashkin, D. P., Elashoff, R., Clements, P. J., Goldin, J., Roth, M. D., Furst, D. E., Arriola, E., Silver, R., Strange, C., Bolster, M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055120 · Cited by 1,677
Tashkin, D. P., Roth, M. D., Clements, P. J., Furst, D. E., Khanna, D., Kleerup, E. C., Goldin, J., Arriola, E., Volkmann, E. R., Kafaja, S., et al. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30152-7 · Cited by 1,078
Dyspnea: Mechanisms, Assessment, and Management: A Consensus Statement
(1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.1.ats898 · Cited by 1,052
Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease
Cooper, J. D., Trulock, E. P., Triantafillou, A. N., Patterson, G. A., Pohl, M. S., Deloney, P. A., Sundaresan, R. S., & Roper, C. L. (1995) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(95)70426-4 · Cited by 896
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
Casaburi, R., Mahler, D. A., Jones, P. W., Wanner, A., San Pedro, G., ZuWallack, R. L., Menjoge, S. S., Serby, C. W., & Witek, T. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00269802 · Cited by 881
Self-citationMeta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease
Lacasse, Y., Wong, E., Guyatt, G. H., King, D., Cook, D. J., & Goldstein, R. S. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04201-8 · Cited by 868
Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD
O'Donnell, D. E., Flüge, T., Gerken, F., Hamilton, A., Webb, K., Aguilaniu, B., Make, B., & Magnussen, H. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00116004 · Cited by 859
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Cazzola, M., MacNee, W., Martinez, F. J., Rabe, K. F., Franciosi, L. G., Barnes, P. J., Brusasco, V., Burge, P. S., Calverley, P. M. A., Celli, B. R., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00099306 · Cited by 858
Self-citationRoflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
Calverley, P. M., Rabe, K. F., Goehring, U.-M., Kristiansen, S., Fabbri, L. M., & Martinez, F. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61255-1 · Cited by 829
Pulmonary rehabilitation for chronic obstructive pulmonary disease
Lacasse, Y., Goldstein, R., Lasserson, T. J., & Martin, S. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003793.pub2 · Cited by 821
Dyspnea Mechanisms, Assessment and Management: A Consensus Statement
Editorial, A. (2005) · PULMONOLOGIYA · doi:10.18093/0869-0189-2005-0-2-9-36 · Cited by 808
Depressive Symptoms and Health-Related Quality of Life: The Heart and Soul Study
Ruo, B., Rumsfeld, J. S., Hlatky, M. A., Liu, H., Browner, W. S., & Whooley, M. A. (2003) · JAMA · doi:10.1001/jama.290.2.215 · Cited by 747
Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium
Vincken, W., van Noord, J. A., Greefhorst, A. P. M., Bantje, T. A., Kesten, S., Korducki, L., & Cornelissen, P. J. G. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00238702 · Cited by 736
BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
King, T. E., Brown, K. K., Raghu, G., du Bois, R. M., Lynch, D. A., Martinez, F., Valeyre, D., Leconte, I., Morganti, A., Roux, S., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201011-1874oc · Cited by 718
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
Raghu, G., Brown, K. K., Bradford, W. Z., Starko, K., Noble, P. W., Schwartz, D. A., & King, T. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030511 · Cited by 652
Aaron, S. D., Vandemheen, K. L., Fergusson, D., Maltais, F., Bourbeau, J., Goldstein, R., Balter, M., O'Donnell, D., McIvor, A., Sharma, S., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-8-200704170-00152 · Cited by 649
The Clinical Course of Patients with Idiopathic Pulmonary Fibrosis
Martinez, F. J., Safrin, S., Weycker, D., Starko, K. M., Bradford, W. Z., King, T. E., Flaherty, K. R., Schwartz, D. A., Noble, P. W., Raghu, G., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-12_part_1-200506210-00005 · Cited by 622
Fabbri, L. M., Calverley, P. M., Izquierdo-Alonso, J. L., Bundschuh, D. S., Brose, M., Martinez, F. J., & Rabe, K. F. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61252-6 · Cited by 614
The 6‐min walk distance: change over time and value as a predictor of survival in severe COPD
Pinto-Plata, V. M., Cote, C., Cabral, H., Taylor, J., & Celli, B. R. (2004) · European Respiratory Journal · doi:10.1183/09031936.03.00034603 · Cited by 593
High-Resolution Computed Tomography in Idiopathic Pulmonary Fibrosis: Diagnosis and Prognosis
Lynch, D. A., Godwin, J. D., Safrin, S., Starko, K. M., Hormel, P., Brown, K. K., Raghu, G., King, T. E., Bradford, W. Z., Schwartz, D. A., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200412-1756oc · Cited by 547
O'Donnell, D. E., & Webb, K. A. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.5.1351 · Cited by 543
Randomised controlled trial of respiratory rehabilitation
GOLDSTEIN, R. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90568-1 · Cited by 541
O'DONNELL, D. E., LAM, M., & WEBB, K. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.5.9804004 · Cited by 532
Depressive symptoms and risk of functional decline and death in patients with heart failure
Vaccarino, V., Kasl, S. V., Abramson, J., & Krumholz, H. M. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01334-1 · Cited by 528
Efficacy of Salmeterol Xinafoate in the Treatment of COPD
Mahler, D. A., Donohue, J. F., Barbee, R. A., Goldman, M. D., Gross, N. J., Wisniewski, M. E., Yancey, S. W., Zakes, B. A., Rickard, K. A., & Anderson, W. H. (1999) · Chest · doi:10.1378/chest.115.4.957 · Cited by 520
Self-citationCooper, J. D., Patterson, G. A., Sundaresan, R. S., Trulock, E. P., Yusen, R. D., Pohl, M. S., & Lefrak, S. S. (1996) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(96)70147-2 · Cited by 518
Ries, A. L., Carlin, B. W., Carrieri-Kohlman, V., Casaburi, R., Celli, B. R., Emery, C. F., Hodgkin, J. E., Mahler, D. A., Make, B., & Skolnick, J. (1997) · Chest · doi:10.1378/chest.112.5.1363 · Cited by 502
Self-citationMahler, D. A., Wire, P., Horstman, D., Chang, C.-N., Yates, J., Fischer, T., & Shah, T. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2112055 · Cited by 495
Self-citationO'DONNELL, D. E., LAM, M., & WEBB, K. A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9901038 · Cited by 485
Martínez-García, M. A., Soler-Cataluña, J.-J., Perpiñá-Tordera, M., Román-Sánchez, P., & Soriano, J. (2007) · Chest · doi:10.1378/chest.07-0490 · Cited by 483
Donohue, J. F., van Noord, J. A., Bateman, E. D., Langley, S. J., Lee, A., Witek, T. J., Kesten, S., & Towse, L. (2002) · Chest · doi:10.1378/chest.122.1.47 · Cited by 471
Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease
Tashkin, D. P., Elashoff, R., Clements, P. J., Roth, M. D., Furst, D. E., Silver, R. M., Goldin, J., Arriola, E., Strange, C., Bolster, M. B., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200702-326oc · Cited by 464
Sciurba, F. C., Rogers, R. M., Keenan, R. J., Slivka, W. A., Gorcsan, J., Ferson, P. F., Holbert, J. M., Brown, M. L., & Landreneau, R. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604253341704 · Cited by 462
The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease
Rennard, S. I., Fogarty, C., Kelsen, S., Long, W., Ramsdell, J., Allison, J., Mahler, D., Saadeh, C., Siler, T., Snell, P., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-995oc · Cited by 439
Self-citationHow should we measure function in patients with chronic heart and lung disease?
Guyatt, G. H., Thompson, P. J., Berman, L. B., Sullivan, M. J., Townsend, M., Jones, N. L., & Pugsley, S. O. (1985) · Journal of Chronic Diseases · doi:10.1016/0021-9681(85)90035-9 · Cited by 432
Brusasco, V (2005) · Thorax · doi:10.1136/thx.2005.brusascolett · Cited by 431
Validation of a New Dyspnea Measure
Eakin, E. G., Resnikoff, P. M., Prewitt, L. M., Ries, A. L., & Kaplan, R. M. (1998) · Chest · doi:10.1378/chest.113.3.619 · Cited by 422
Brusasco, V (2003) · Thorax · doi:10.1136/thorax.58.5.399 · Cited by 409
Ries, A. L. (2005) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1081/copd-200050655 · Cited by 405
Scientific and Clinical Problems in Indexes of Functional Disability
FEINSTEIN, A. R., JOSEPHY, B. R., & WELLS, C. K. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-3-413 · Cited by 395
Self-citationCasaburi, R., Kukafka, D., Cooper, C. B., Witek, T. J., & Kesten, S. (2005) · Chest · doi:10.1378/chest.127.3.809 · Cited by 381
Clinical significance of histological classification of idiopathic interstitial pneumonia
Flaherty, K. R., Toews, G. B., Travis, W. D., Colby, T. V., Kazerooni, E. A., Gross, B. H., Jain, A., Strawderman, R. L., Paine, R., Flint, A., et al. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00182002 · Cited by 372
Maintenance after Pulmonary Rehabilitation in Chronic Lung Disease: A Randomized Trial
Ries, A. L., Kaplan, R. M., Myers, R., & Prewitt, L. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200204-318oc · Cited by 371
Bucher, H. C., Guyatt, G. H., Cook, D. J., Holbrook, A., McAlister, F. A., & for the Evidence-Based Medicine Working Group (1999) · JAMA · doi:10.1001/jama.282.8.771 · Cited by 361
Ofir, D., Laveneziana, P., Webb, K. A., Lam, Y.-M., & O'Donnell, D. E. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1064oc · Cited by 358
Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease: Indacaterol Versus Tiotropium
Donohue, J. F., Fogarty, C., Lötvall, J., Mahler, D. A., Worth, H., Yorgancioğlu, A., Iqbal, A., Swales, J., Owen, R., Higgins, M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200910-1500oc · Cited by 358
Self-citationOutpatient Oral Prednisone after Emergency Treatment of Chronic Obstructive Pulmonary Disease
Aaron, S. D., Vandemheen, K. L., Hebert, P., Dales, R., Stiell, I. G., Ahuja, J., Dickinson, G., Brison, R., Rowe, B. H., Dreyer, J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa023161 · Cited by 350
Outcomes in heart failure patients with preserved ejection fraction
Smith, G. L., Masoudi, F. A., Vaccarino, V., Radford, M. J., & Krumholz, H. M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00185-2 · Cited by 335
Multidimensional Dyspnea Profile: an instrument for clinical and laboratory research
Banzett, R. B., O'Donnell, C. R., Guilfoyle, T. E., Parshall, M. B., Schwartzstein, R. M., Meek, P. M., Gracely, R. H., & Lansing, R. W. (2015) · European Respiratory Journal · doi:10.1183/09031936.00038914 · Cited by 330
Hanania, N. A., Darken, P., Horstman, D., Reisner, C., Lee, B., Davis, S., & Shah, T. (2003) · Chest · doi:10.1378/chest.124.3.834 · Cited by 327
Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis
NISHIYAMA, O., KONDOH, Y., KIMURA, T., KATO, K., KATAOKA, K., OGAWA, T., WATANABE, F., ARIZONO, S., NISHIMURA, K., & TANIGUCHI, H. (2008) · Respirology · doi:10.1111/j.1440-1843.2007.01205.x · Cited by 316
Mahler, D. A., & Mackowiak, J. I. (1995) · Chest · doi:10.1378/chest.107.6.1585 · Cited by 311
Self-citationA critical look at transition ratings
Guyatt, G. H., Norman, G. R., Juniper, E. F., & Griffith, L. E. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00435-3 · Cited by 298
Efficacy of Different Treatment Alternatives for Obesity Hypoventilation Syndrome. Pickwick Study
Masa, J. F., Corral, J., Alonso, M. L., Ordax, E., Troncoso, M. F., Gonzalez, M., Lopez-Martínez, S., Marin, J. M., Marti, S., Díaz-Cambriles, T., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201410-1900oc · Cited by 293
Guyatt, G. H. (1997) · JAMA · doi:10.1001/jama.1997.03540390062037 · Cited by 289
McEVOY, C. E., ENSRUD, K. E., BENDER, E., GENANT, H. K., YU, W., GRIFFITH, J. M., & NIEWOEHNER, D. E. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.9703080 · Cited by 285
Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial
Raghu, G., Million-Rousseau, R., Morganti, A., Perchenet, L., Behr, J., & the MUSIC Study Group (2013) · European Respiratory Journal · doi:10.1183/09031936.00104612 · Cited by 277
Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
Walters, J. A., Gibson, P. G., Wood-Baker, R., Hannay, M., & Walters, E. H. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001288.pub3 · Cited by 279
Decramer, M. L., Chapman, K. R., Dahl, R., Frith, P., Devouassoux, G., Fritscher, C., Cameron, R., Shoaib, M., Lawrence, D., Young, D., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70158-9 · Cited by 277
Measurement of breathlessness in advanced disease: A systematic review
Bausewein, C., Farquhar, M., Booth, S., Gysels, M., & Higginson, I. J. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2006.07.003 · Cited by 274
Dahl, R., Chung, K. F., Buhl, R., Magnussen, H., Nonikov, V., Jack, D., Bleasdale, P., Owen, R., Higgins, M., Kramer, B., et al. (2010) · Thorax · doi:10.1136/thx.2009.125435 · Cited by 273
Strumpf, D. A., Millman, R. P., Carlisle, C. C., Grattan, L. M., Ryan, S. M., Erickson, A. D., & Hill, N. S. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.6.1234 · Cited by 272
Applications of the medical outcomes study health-related quality of life measures in HIV/AIDS
Wu, A. W., Hays, R. D., Kelly, S., Malitz, F., & Bozzette, S. A. (1997) · Quality of Life Research · doi:10.1023/a:1018460132567 · Cited by 269
HAJIRO, T., NISHIMURA, K., TSUKINO, M., IKEDA, A., KOYAMA, H., & IZUMI, T. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.9703055 · Cited by 265
Efficacy and Safety of a Monoclonal Antibody Recognizing Interleukin-8 in COPD
Mahler, D. A., Huang, S., Tabrizi, M., & Bell, G. M. (2004) · Chest · doi:10.1378/chest.126.3.926 · Cited by 261
Self-citationde Torres, J. P., Pinto-Plata, V., Ingenito, E., Bagley, P., Gray, A., Berger, R., & Celli, B. (2002) · Chest · doi:10.1378/chest.121.4.1092 · Cited by 261
Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD
Donohue, J. F., Maleki-Yazdi, M. R., Kilbride, S., Mehta, R., Kalberg, C., & Church, A. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.06.001 · Cited by 259
Salmeterol Plus Theophylline Combination Therapy in the Treatment of COPD
ZuWallack, R. L., Mahler, D. A., Reilly, D., Church, N., Emmett, A., Rickard, K., & Knobil, K. (2001) · Chest · doi:10.1378/chest.119.6.1661 · Cited by 258
Self-citationHAJIRO, T., NISHIMURA, K., TSUKINO, M., IKEDA, A., KOYAMA, H., & IZUMI, T. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.4.9802091 · Cited by 255
Cahalin, L., Pappagianopoulos, P., Prevost, S., Wain, J., & Ginns, L. (1995) · Chest · doi:10.1378/chest.108.2.452 · Cited by 254
Ventilatory and perceptual responses to cycle exercise in obese women
Ofir, D., Laveneziana, P., Webb, K. A., & O'Donnell, D. E. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00898.2006 · Cited by 176
O'Donnell, D. E., Webb, K. A., Bertley, J. C., Chau, L. K. L., & Conlan, A. A. (1996) · Chest · doi:10.1378/chest.110.1.18 · Cited by 154
Yorke, J., Jones, P. W., & Swigris, J. J. (2010) · Thorax · doi:10.1136/thx.2010.139121 · Cited by 147
Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations
Glaab, T., Vogelmeier, C., & Buhl, R. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-79 · Cited by 130
“, baseline (BDI)), and measuring changes in breathlessness from this baseline state over time (TDI) [40].”
BackgroundDoes the Respiratory System Limit Exercise in Mild Chronic Obstructive Pulmonary Disease?
Chin, R. C., Guenette, J. A., Cheng, S., Raghavan, N., Amornputtisathaporn, N., Cortés-Télles, A., Webb, K. A., & O’Donnell, D. E. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201211-1970oc · Cited by 123
Fraticelli, P., Gabrielli, B., Pomponio, G., Valentini, G., Bosello, S., Riboldi, P., Gerosa, M., Faggioli, P., Giacomelli, R., Del Papa, N., et al. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4606 · Cited by 108
Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD
O'Donnell, D. E., Laveneziana, P., Ora, J., Webb, K. A., Lam, Y.-M., & Ofir, D. (2009) · Thorax · doi:10.1136/thx.2008.103598 · Cited by 104
TNFα Antagonists for Acute Exacerbations of COPD: A Randomised Double-Blind Controlled Trial
Aaron, S. D., Vandemheen, K. L., Maltais, F., Field, S. K., Sin, D. D., Bourbeau, J., Marciniuk, D. D., FitzGerald, J. M., Nair, P., & Mallick, R. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202432 · Cited by 103
“An independent Data Safety Monitoring Board did oversee the trial and monitor all adverse events on a quarterly basis but did not advise early stopping at any point during the study.”
BackgroundEffect of obesity on respiratory mechanics during rest and exercise in COPD
Ora, J., Laveneziana, P., Wadell, K., Preston, M., Webb, K. A., & O'Donnell, D. E. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01131.2010 · Cited by 101
Mechanisms of exertional dyspnoea in symptomatic smokers without COPD
Elbehairy, A. F., Guenette, J. A., Faisal, A., Ciavaglia, C. E., Webb, K. A., Jensen, D., Ramsook, A. H., Neder, J. A., & O'Donnell, D. E. (2016) · European Respiratory Journal · doi:10.1183/13993003.00077-2016 · Cited by 99
Sex differences in exertional dyspnea in patients with mild COPD: Physiological mechanisms
Guenette, J. A., Jensen, D., Webb, K. A., Ofir, D., Raghavan, N., & O’Donnell, D. E. (2011) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2011.04.011 · Cited by 83
Physiologic correlates of dyspnea in patients with morbid obesity
Collet, F., Mallart, A., Bervar, J. F., Bautin, N., Matran, R., Pattou, F., Romon, M., & Perez, T. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803460 · Cited by 72
Current Dyspnea Among Long-Term Survivors of Early-Stage Non-small Cell Lung Cancer
Feinstein, M. B., Krebs, P., Coups, E. J., Park, B. J., Steingart, R. M., Burkhalter, J., Logue, A., & Ostroff, J. S. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181df61c8 · Cited by 56
KELLER, C. A., RUPPEL, G., HIBBETT, A., OSTERLOH, J., & NAUNHEIM, K. S. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.1.9609101 · Cited by 59
Clinical Utility of Measures of Breathlessness
Cullen, D. L., & Rodak, B. (2002) · Respiratory Care · doi:10.1177/002013240204700902 · Cited by 54
Effects of formoterol on exercise tolerance in severely disabled patients with COPD
Neder, J. A., Fuld, J. P., Overend, T., Thirlwell, J., Carter, R., Stevenson, R., & Ward, S. A. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.06.006 · Cited by 47
Walking exercise response to bronchodilation in mild COPD: A randomized trial
Gagnon, P., Saey, D., Provencher, S., Milot, J., Bourbeau, J., Tan, W. C., Martel, S., & Maltais, F. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.08.021 · Cited by 21
Metadata
- Authors
- Mahler, D. A., Weinberg, D. H., Wells, C. K., & Feinstein, A. R.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 1984-06
- Volume
- 85
- Issue
- 6
- Pages
- 751-758
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2166780351
- Cited by
- 1,292
- References
- 24
- FWCI
- 11.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.